(NASDAQ: KOD) Kodiak Sciences's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 44.21%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 42.48%.
Kodiak Sciences's earnings in 2025 is -$217,336,000.On average, 9 Wall Street analysts forecast KOD's earnings for 2025 to be -$228,033,973, with the lowest KOD earnings forecast at -$232,903,818, and the highest KOD earnings forecast at -$215,005,279. On average, 8 Wall Street analysts forecast KOD's earnings for 2026 to be -$185,653,583, with the lowest KOD earnings forecast at -$249,019,931, and the highest KOD earnings forecast at -$96,362,469.
In 2027, KOD is forecast to generate -$172,311,904 in earnings, with the lowest earnings forecast at -$259,417,423 and the highest earnings forecast at -$65,169,994.